Knowledge & Skills Economy
Tap into the growing market for lifelong learning and professional development. These carefully selected companies are at the forefront of educational innovation, from digital platforms to specialized training services. Our analysts have identified the leaders in this expanding sector.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Strategic Education Inc
STRA
Current price
$79.37
Offers a wide range of post-secondary education through well-known institutions like Strayer and Capella Universities, directly serving the adult lear...
Offers a wide range of post-secondary education through well-known institutions like Strayer and Capella Universities, directly serving the adult learner market.
UDEMY, INC.
UDMY
Current price
$6.90
Operates a vast global marketplace for online courses, enabling individuals and organizations to access a wide array of professional and technical ski...
Operates a vast global marketplace for online courses, enabling individuals and organizations to access a wide array of professional and technical skills training.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
This collection focuses on companies powering the global shift toward continuous learning and skills enhancement. As technology transforms careers and workplaces evolve, these businesses provide the tools, content, and platforms that make education more accessible, flexible, and career-relevant.
What You Need to Know
This theme offers exposure to a resilient growth sector with strong long-term potential. Companies range from K-12 digital platforms to professional certification providers, creating a diverse portfolio that captures multiple segments of the education market.
Why These Stocks
These companies were selected for their innovation in educational delivery, strong positioning in high-demand learning markets, and ability to scale through technology. Each addresses critical needs in today's knowledge-based economy, from early education to advanced professional development.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+14.77%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 14.77% over the next year.
Stocks Rated Buy by Analysts
15 of 16 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 1.7% return last month.
Why You'll Want to Watch These Stocks
AI Revolution in Learning
Artificial intelligence is transforming education with personalized learning paths. Companies integrating AI into their platforms are seeing accelerated growth and expanded market reach.
Corporate Skills Gap Opportunity
Businesses worldwide are investing heavily in upskilling their workforce. The companies that provide these training solutions are positioned to benefit from this sustained corporate spending trend.
Global Education Access
Digital platforms are breaking down geographical barriers to quality education. Companies that can scale across borders are tapping into massive new markets previously unreachable.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.